Lake Shore Gazette

Leading News Website

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market 2019 Industry Trend, Share, Size, Application, Key Manufacturers & Forecast – 2029

Endoscopic retrograde cholangiopancreatography (ERCP) devices utilizes a combination of fluoroscopic imaging and luminal endoscopy for the diagnosis and treatment of pancreatobiliary system related disorders. Endoscopic retrograde cholangiopancreatography (ERCP) devices use a side-view duodenoscope which is further passed via esophagus and stomach into the latter section of the duodenum. Endoscopic retrograde cholangiopancreatography (ERCP) devices are majorly used for collecting samples of tissue and cells or to treat a blocked pancreatic or bile duct. The blockage of the ducts could be caused by stones in the duct (non-cancerous cases) or by cancer. Imaging tests that are safer and less invasive than an endoscopic retrograde cholangiopancreatography (ERCP) device, are used for diagnosis or for examining the pancreatic ducts, also, gallbladder, liver, and pancreas. Alternatives for endoscopic retrograde cholangiopancreatography (ERCP) devices include magnetic resonance cholangiopancreatography devices and computed tomography machines. Endoscopic retrograde cholangiopancreatography (ERCP) devices are used for various procedures like, sphincterotomy, stone removal, stent placement, dilatation, draining fluids from the body, etc.

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market: Drivers and Restraints-

Endoscopic retrograde cholangiopancreatography (ECRP) devices have gained immense popularity for cancer treatment over the years. Growing incidence of benign tumors of the liver and pancreas is expected to create attractive market opportunities for the endoscopic retrograde cholangiopancreatography (ECRP) devices across regions during the forecast period. Several ongoing researches for safer use and improved efficiency of these endoscopic retrograde cholangiopancreatography (ECRP) devices and growing government support for R&D could also propel market growth for endoscopic retrograde cholangiopancreatography (ECRP) devices throughout the forecast period. Growing awareness on endoscopic retrograde cholangiopancreatography (ECRP) devices and increase in availability is also expected to fuel market growth for endoscopic retrograde cholangiopancreatography (ECRP) devices. On the contrary, high costs associated with endoscopic retrograde cholangiopancreatography (ECRP) devices and side effects such as post-ERCP pancreatitis, infection, hemorrhage, and allergic reactions that are associated with cholangiopancreatography procedures is expected to obstruct market growth for endoscopic retrograde cholangiopancreatography (ECRP) devices during the forecast period.

Download sample copy of this report:
https://www.futuremarketinsights.com/reports/sample/REP-GB-9658

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market: Segmentation

On the basis of disease indication, Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market can be segmented as:

  • Gastroesophageal Reflux Disease
  • GI Cancer
  • Barrett’s Esophagus
  • Bile Duct Diseases
  • Peptic Ulcer Disease
  • Crohn’s Disease
  • Intestinal Pseudo-Obstruction and Ogilvie Syndrome
  • Others

On the basis of product type, Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market can be segmented as:

  • Sphincterotomes
  • Lithotripter
  • Endoscopes
  • Accessories Stents Cannulas Forceps Snares Catheters Guiding Wires Balloons Baskets Others

On the basis of End User, Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market can be segmented as:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories
  • Others

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market: Overview

Endoscopic retrograde cholangiopancreatography (ECRP) devices involve advanced techniques, and therefore, is linked to a higher frequency of serious complications than other endoscopic procedures. Consequently, specialized equipment and training are required, and the procedure is conducted for suitable applications. A review by Freeman et al estimated that approximately 500,000 procedures are performed United States each year. Often endoscopic retrograde cholangiopancreatography (ECRP) devices are used in hospital settings wherein patients are admitted with pancreatic or gallstones disease. Different indications that involve the use of endoscopic retrograde cholangiopancreatography (ECRP) devices are tissue sampling or biliary or pancreatic ductal system disease treatment, obstructive jaundice, pancreatitis of unknown cause, suspicion for pancreatic cancer, nasobiliary drainage, manometry for sphincter of Oddi, biliary stenting for leakage and strictures, balloon dilation of ductal strictures and duodenal papill and drainage of pancreatic pseudocysts.

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market: Region-wise Outlook

North America market for endoscopic retrograde cholangiopancreatography (ECRP) devices is expected to grow significantly owing it to the increased diagnostic imaging related researches and enhanced research and development for advanced and safe endoscopic retrograde cholangiopancreatography (ECRP) devices in the market. Improved healthcare infrastructure and expenditure is anticipated to fuel the Europe market for endoscopic retrograde cholangiopancreatography (ECRP) devices during the forecast period. Growing awareness on cholangiopancreatography procedures in China, India, and Japan is also anticipated to fuel the market for endoscopic retrograde cholangiopancreatography (ECRP) devices in the Asia-Pacific region. Constant increase in number of endoscopic retrograde cholangiopancreatography (ECRP) devices manufacturers is expected to propel demand for endoscopic retrograde cholangiopancreatography (ECRP) devices during the forecast period.

Download table of contents with figures & tables:
https://www.futuremarketinsights.com/askus/rep-gb-9658

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market: Key Market Participants

A few market participants in the global endoscopic retrograde cholangiopancreatography (ECRP) devices market identified across the value chain include: Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Hobbs Medical, Merit Medical Systems and , TeleMed Systems, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *